Effectiveness of 3D-printed Patient-specific Resorbable Scaffolds for Maxillary Bone Regeneration

Launched by UNIVERSIDAD AUSTRAL DE CHILE · Jan 12, 2025

Keywords

ClinConnect Summary

A parallel-arm randomized clinical trial will be designed. The participants will be elderly patients from the city of Valdivia, Chile, regardless of sex, from the Dental Health Service of the Base Hospital of Valdivia for dental rehabilitation with dental implants. Clinical characteristics and complete medical history (such as sex, age and comorbidities) will be recorded and all the information that allows the identification of the patients will be encrypted.

Patients requiring bone regeneration at the time of examination should have an atrophic bilateral mandible with poor bone available ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients from the city of Valdivia, Chile, from Dental Health Service of the Base Hospital of Valdivia for the rehabilitation of their teeth with dental implants,
• • age between 30 and 70 years old,
• • regardless of sex,
• • complete medical history (such as sex, age and comorbidities) will be recorded.
• • patients requiring bone regeneration at the time of examination should have an atrophic bilateral mandible with poor bone available according to periodontal deseases classification behind tooth #3.3 or #4.3; with an edentulous alveolar ridge with a remaining bone height of ≤ 6 mm.
• Exclusion Criteria:
• • patients had previous dental implant surgeries,
• • with maxillary sinus pathologies or oral tissue lesions,
• • diseases that produce acute/chronic pain,
• • smokers of more than 5 cigarettes per day,
• • with excessive alcohol consumption (more than three times per week),
• • who suffer from any systemic disease whose surgical intervention is prohibited, for example: severe heart disease, congenital coagulation factor deficiency, dialysis, or malignant tumor in terminal phase,
• • patients with diabetes that is not well controlled or who have difficulty achieving an Hb ≥ 7 g/dL in a preoperative examination,
• • patients taking any antiplatelet or anticoagulant drug,
• • patients with a history of heart disease.